The Bmi-1 Helix–turn and Ring Finger Domains Are Required for Bmi-1 Antagonism of (−) Epigallocatechin-3-Gallate Suppression of Skin Cancer Cell Survival

Cellular Signalling - United States
doi 10.1016/j.cellsig.2015.03.021
Full Text
Abstract

Available in full text

Categories
Cell Biology
Date
Authors
Publisher

Elsevier BV

Related search

Three Distinct Domains of SSI-1/SOCS-1/JAB Protein Are Required for Its Suppression of Interleukin 6 Signaling

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Bmi-1 Regulates Stem Cell-Like Properties of Gastric Cancer Cells via Modulating miRNAs

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Socioeconomic Deprivation and Survival in Endometrial Cancer: The Effect of BMI

Gynecologic Oncology
GynecologyOncologyObstetrics
2020English

Negative Regulation of Bmi-1 by AMPK and Implication in Cancer Progression

Oncotarget
Oncology
2015English

Enhancing Chemotherapy Response With Bmi-1 Silencing in Ovarian Cancer

PLoS ONE
Multidisciplinary
2011English

Checkpoint With Forkhead and Ring Finger Domains (CHFR); Histone Deacetylase 1 (HDAC1)

Science-Business eXchange
2009English

Cancer Therapeutics With Epigallocatechin-3-Gallate Encapsulated in Biopolymeric Nanoparticles

International Journal of Pharmaceutics
Pharmaceutical Science
2017English

The Relation of Weight Suppression and BMI to Bulimic Symptoms

International Journal of Eating Disorders
PsychiatryMental Health
2010English

Inhibitory Effect of (−)-Epigallocatechin-3-Gallate and Bleomycin on Human Pancreatic Cancer MIA Paca-2 Cell Growth

European Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy